Literature DB >> 10881177

Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2.

J D Farrar1, J D Smith, T L Murphy, S Leung, G R Stark, K M Murphy.   

Abstract

The use of murine systems to model pathogen-induced human diseases presumes that general immune mechanisms between these species are conserved. One important immunoregulatory mechanism involves linkage of innate and adaptive immunity to direct the development of T helper subsets, for example toward subset 1 (TH1) development through STAT4 activation. In analyzing type I interferon signaling, we uncovered a difference between murine and human cells which may affect how these two species control linkage between innate and adaptive immunity. We show that in humans, type I interferons induce TH1 development and can activate STAT4 by recruitment to the IFN-alpha receptor complex specifically via the carboxy-terminus of STAT2. However, the mouse Stat2 gene harbors a minisatellite insertion that has altered the carboxy-terminus and selectively disrupted its capacity to activate STAT4, but not other STATs. This defect in murine Stat2 suggests that the signals leading to STAT4 activation and TH1 development in CD4+ T cells are different between mice and humans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10881177     DOI: 10.1038/76932

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  55 in total

Review 1.  T helper subset development: roles of instruction, selection, and transcription.

Authors:  J David Farrar; Helene Asnagli; Kenneth M Murphy
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

Review 2.  IFNs and STATs in innate immunity to microorganisms.

Authors:  Thomas Decker; Silvia Stockinger; Marina Karaghiosoff; Mathias Müller; Pavel Kovarik
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

3.  Infection with the intracellular bacterium, Listeria monocytogenes, overrides established tolerance in a mouse cardiac allograft model.

Authors:  T Wang; E B Ahmed; L Chen; J Xu; J Tao; C-R Wang; M-L Alegre; A S Chong
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

Review 4.  The role of signal transducer and activator of transcription-2 in the interferon response.

Authors:  Håkan C Steen; Ana M Gamero
Journal:  J Interferon Cytokine Res       Date:  2012-01-26       Impact factor: 2.607

Review 5.  Fate vs choice: the immune system reloaded.

Authors:  Kenneth M Murphy
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

6.  Blockade of virus infection by human CD4+ T cells via a cytokine relay network.

Authors:  Ann M Davis; Kristan A Hagan; Loderick A Matthews; Gagan Bajwa; Michelle A Gill; Michael Gale; J David Farrar
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

7.  IFN-alpha is not sufficient to drive Th1 development due to lack of stable T-bet expression.

Authors:  Hilario J Ramos; Ann M Davis; Thaddeus C George; J David Farrar
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

Review 8.  Regulation of effector and memory T-cell functions by type I interferon.

Authors:  Jonathan P Huber; J David Farrar
Journal:  Immunology       Date:  2011-02-14       Impact factor: 7.397

Review 9.  Murine Models of Sepsis and Trauma: Can We Bridge the Gap?

Authors:  Julie A Stortz; Steven L Raymond; Juan C Mira; Lyle L Moldawer; Alicia M Mohr; Philip A Efron
Journal:  ILAR J       Date:  2017-07-01

10.  Aerosolized gamma interferon (IFN-gamma) induces expression of the genes encoding the IFN-gamma-inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis.

Authors:  Bindu Raju; Yoshihiko Hoshino; Kenichi Kuwabara; Ilana Belitskaya; Savita Prabhakar; Antony Canova; Jeffrey A Gold; Rany Condos; Richard I Pine; Stuart Brown; William N Rom; Michael D Weiden
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.